Skip to content

To develop and evaluate the efficacy of fumigation device of external auditory canal in the management of ear discharge

To develop and evaluate the efficacy of Karnadhoopan device with conventional Karnadhoopan in the management of Karnasrav with special reference to chronic suppurative otitis media a randomized controlled clinical trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/054829
Enrollment
40
Registered
2023-07-06
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H660- Acute suppurative otitis media

Interventions

None listed

Sponsors

Dr Radhika Gandhi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients presenting with features of karnasrav, safe or tubotympanic chronic suppurative otitis media without complications

Exclusion criteria

Exclusion criteria: Patients aged below 10 years and above 60 years Attic, marginal and total perforation of tympanic membrane Patients with severe conductive sensorineural and mixed deafness Patients with blood stained ear discharge Ear discharge associated with complications and other systemic disorders Advancement of disesase with pre malignant or malignant changes

Design outcomes

Primary

MeasureTime frame
Patients will have improve in ear dischargeTimepoint: first day, 15th day and 21st day

Secondary

MeasureTime frame
Patients will have improve in earache, itching and impaired hearingTimepoint: Day 7 Day 14 Day 21

Countries

India

Contacts

Public ContactDr Radhika Gandhi

Parul Institute of Ayurved ,Parul University

manjirikeskar@gmail.com9822606358

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026